(Q36786062)

16 August 2017

1 reference

title

Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate (English)

1 reference

16 August 2017

1 reference

3

Ellen S Vitetta

1 reference

16 August 2017

2

Jonathan W Uhr

1 reference

16 August 2017

Rosalia Rabinovsky

1

1 reference

16 August 2017

Eitan Yefenof

series ordinal

4

1 reference

16 August 2017

publication date

1 January 2007

1 reference

Advances in Cancer Research

16 August 2017

published in

1 reference

16 August 2017

volume

97

1 reference

16 August 2017

page(s)

189-202

1 reference

Biochemistry of HER2 oncogenesis in breast cancer.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Expression of erbB receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Anti-idiotype antibody vaccine therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

p53 oncogene mutations in three human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

CD22 as a target of passive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Splitting hairs--discovery of a new DNA repair and transcription factor for the human disease trichothiodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Herceptin: breaking new ground

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Herceptin: from the bench to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Genomic instability and cancer: networks involved in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Imaging transgene expression in live animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Herceptin: implications for breast cancer management

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Cancer, apoptosis, and nonimmune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Surveillance against tumors--is it mainly immunological?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Circulating tumor cells in patients with breast cancer dormancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Involvement of N-acetylcysteine-sensitive pathways in ricin-induced apoptotic cell death in U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

1 reference

7 January 2021

Effect of p53 on centrosome amplification in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Detection and clinical importance of micrometastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Detection and characterization of carcinoma cells in the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Microenvironmental regulation of the initiated cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Solitary metastasis of renal cell carcinoma to the contralateral adrenal gland 22 years after nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin’s lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Spontaneous murine B-cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Immunotherapy with anti-CD20 compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Comparison of ribosome-inactivating proteins in the induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Biology of HER2 and its importance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Cancer dormancy: isolation and characterization of dormant lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

Induction of B cell tumor dormancy by anti-idiotypic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2997008-0

7 January 2021

10.1016/S0065-230X(06)97008-0

Identifiers

DOI

1 reference

16 August 2017

1 reference